Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Atzler

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Amino Acids|November 1, 2016
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam studyJanine Wirth, Dorothee Atzler, Romina di Giuseppe, et al.
International Journal of Cardiology|July 30, 2013
Homoarginine--an independent marker of mortality in heart failureDorothee Atzler, Mark Rosenberg, Maike Anderssohn, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2015
L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General PopulationTill Ittermann, Martin Bahls, Dorothee Atzler, et al.
Amino Acids|June 17, 2015
Homoarginine supplementation improves blood glucose in diet-induced obese miceMalte Stockebrand, Sönke Hornig, Axel Neu, et al.
Plos One|May 14, 2014
Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomeraniaEdzard Schwedhelm, Henri Wallaschofski, Dorothee Atzler, et al.
Biomolecules|August 1, 2018
Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General PopulationMartin Bahls, Dorothee Atzler, Marcello R P Markus, et al.
Atherosclerosis|August 25, 2009
Symmetric dimethylarginine predicts all-cause mortality following ischemic strokeFriedrich Schulze, Angela M Carter, Edzard Schwedhelm, et al.
Circulation|November 18, 2009
Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginineXinli Hu, Xin Xu, Guangshuo Zhu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2014
Homoarginine and cardiovascular outcome in the population-based Dallas Heart StudyDorothee Atzler, M Odette Gore, Colby R Ayers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2011
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginineXinli Hu, Dorothee Atzler, Xin Xu, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Amino Acids|November 1, 2016
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam studyJanine Wirth, Dorothee Atzler, Romina di Giuseppe, et al.
International Journal of Cardiology|July 30, 2013
Homoarginine--an independent marker of mortality in heart failureDorothee Atzler, Mark Rosenberg, Maike Anderssohn, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2015
L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General PopulationTill Ittermann, Martin Bahls, Dorothee Atzler, et al.
Amino Acids|June 17, 2015
Homoarginine supplementation improves blood glucose in diet-induced obese miceMalte Stockebrand, Sönke Hornig, Axel Neu, et al.
Plos One|May 14, 2014
Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomeraniaEdzard Schwedhelm, Henri Wallaschofski, Dorothee Atzler, et al.
Biomolecules|August 1, 2018
Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General PopulationMartin Bahls, Dorothee Atzler, Marcello R P Markus, et al.
Atherosclerosis|August 25, 2009
Symmetric dimethylarginine predicts all-cause mortality following ischemic strokeFriedrich Schulze, Angela M Carter, Edzard Schwedhelm, et al.
Circulation|November 18, 2009
Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginineXinli Hu, Xin Xu, Guangshuo Zhu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2014
Homoarginine and cardiovascular outcome in the population-based Dallas Heart StudyDorothee Atzler, M Odette Gore, Colby R Ayers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2011
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginineXinli Hu, Dorothee Atzler, Xin Xu, et al.
Pageof 8